🔗 Share this article

An underground economy for unlicensed weight-loss drugs is being driven by social media fitness personalities and vendors on communication apps, based on new investigations.

Investigational Treatment Gaining Traction Online

Retatrutide, which remains in clinical trials, is being promoted by online personalities for its supposed fat-burning properties. Viewers are urged to contact these accounts privately for supplier links, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where communities with thousands of participants share “before and after” images, injection guides and assertions of next-day UK delivery. Vendors promote the substance there before redirecting buyers to other platforms for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.

Medical Professionals Voice Concerns

However, doctors and chemists have warned that the sale of what is still an unapproved medication in the UK is a cause for concern and could lead to individuals administering products of uncertain source.

Several experts said the demand for retatrutide could be linked to the rising cost of approved slimming treatments such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate medicines, advertising, and consumer regulations, potentially leading to fines, prosecution or imprisonment.

Service Response and Content Removal

According to the social media company, the platform has removed problematic content and prohibited associated hashtags and search suggestions. The organization stated it was dedicated to maintaining the platform safe and investing in strengthening enforcement strategies.

Digital Trading Activities

Investigations also discovered communities with up to nine thousand members marketing the experimental drug using Telegram's built-in search feature, which operates like a public directory. Typing “retatrutide” instantly displays channels with thousands of members, populated with photos of slimming results, positive reviews and step-by-step instructions for preparing or injecting at residence.

Within moments of entering one community, a seller posted contact information, where the majority of purchases occur. The seller sent an guidebook and guaranteed shipping within two days. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. None asked about body mass, health issues or previous experience.

Product Details and Costs

Inside these communities, messages show black plastic packages with postal service stickers, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at home with sterile water, or ready-to-use pens usually sold at 160 pounds for 20mg. When asked how long a injector should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”.

Service Oversight and Security Actions

A representative for the messaging service stated it regularly monitored dangerous content on its service including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering substances they cannot confirm. Although the science behind this drug is valid, these online versions may not include what they claim,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in interest to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices increasing, individuals are using online platforms. But fake injections are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was clean,” she said.

Her team has previously encountered patients harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from Telegram or communication platforms is taking chances with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a company investigational substance not yet approved … may subject users to possibly serious health risks”.